HIV Incidence Products
Sedia's HIV incidence assays are used to estimate the rate of new HIV infections and monitor the epidemic worldwide.
Rapid Point-of-Care Assays
Sedia develops, markets and licenses rapid point-of-care immuno- diagnostic tests, including oral and other alternative fluid specimens
Specimen Collection Devices
Sedia's specimen collection devices are simple to use, economical and provide quality specimens suitable for a variety of assay technologies

Advancing Access to Care Through Innovation

Sedia Bioscience's mission is to advance global access to healthcare by developing innovative disease surveillance and monitoring tools, expanding accessible point-of-care diagnostic testing into both technology-rich and resource-limited settings and providing cost-effective specimen collection devices.

OUR Products & Technologies

HIV Incidence Assays

Enzyme immunoassays designed to distinguish recent HIV infections from long-term ones as a means to measure incidence of new HIV infections in populations.  We are also developing assays that will target recent infections which have the highest risk of transmission, which pose the greatest risk to others, to enable aggressive treatment, follow-up and customized therapy.

Rapid Point-of-Care Diagnostic Assays

Rapid cost-effective assays that provide diagnostic results from a variety of specimens, including whole and finger-stick blood, serum, plasma, oral fluid, urine and other clinical specimens.  Most of our assays are focused on infectious diseases. However, we are developing rapid assays that identify other disease markers as well.

Specimen Collection Devices

Devices intended to collect, stabilize and transport specimens from the point-of-care to the clinical laboratory.  Designed to be cost effective, robust and to provide a high yield of usable analytes, such as DNA, proteins, antibodies, enzymes and other biomarkers.  We also market low cost, easier-to-use alternatives to classical dried blood spot cards.

Technology LICENSING & COMMERCIALIZATION

We have a variety of licensing and commercial partnership opportunities.  Our technologies are available for licensing to third parties interesting in expanding their technology portfolios, developing improvements to their own technologies, or seeking custom solutions to technological challenges they may encounter.  We are also experienced at commercializing third-party technologies for developers who are seeking to turn their prototypes into commercial products.

Latest News
| Home | About Us | Contact Us | Jobs | Privacy Policy | Terms of Use | Search | Site Map |     © Copyright 2014 - Sedia Biosciences Corporation
Top